Financial Performance - The group's revenue for the fiscal year 2022 was approximately HKD 45.4 million, a decrease of about 21% from HKD 57.5 million in 2021[31]. - The service cost for 2022 was approximately HKD 22.7 million, down from HKD 27.9 million in 2021, aligning with the revenue decrease[32]. - Gross profit decreased by approximately HKD 6.9 million or 23.3% to HKD 22.7 million in 2022, with a gross margin of 50.0% compared to 51.4% in 2021[33]. - The group recorded a net loss of approximately HKD 2.8 million in 2022, compared to a loss of HKD 1.7 million in 2021, primarily due to the revenue decline[38]. - The top five customers accounted for approximately 14.7% of total revenue in 2022, down from 23.1% in 2021, indicating reduced reliance on major clients[30]. - Selling expenses decreased by approximately HKD 0.3 million or 8.3% to HKD 3.3 million in 2022, mainly due to reduced marketing and employee costs[34]. - Administrative expenses decreased by approximately HKD 4.0 million or 13.7% to HKD 25.3 million in 2022, attributed to lower impairment losses and professional fees[35]. - The group did not recommend a final dividend for the fiscal year 2022, consistent with the previous year[43]. - The group’s cash and cash equivalents, along with time deposits, amounted to approximately HKD 68.5 million in 2022, an increase from HKD 65.9 million in 2021[45]. - The current assets were approximately HKD 84.7 million and current liabilities were about HKD 29.6 million, resulting in a current ratio of 2.9 times as of September 30, 2022, down from 3.8 times in 2021[49]. Business Strategy and Outlook - The company emphasized its commitment to enhancing operational efficiency and cost management in response to challenges posed by the COVID-19 pandemic and geopolitical tensions[19]. - The company is optimistic about the long-term prospects of the Hong Kong IPO market, driven by strong momentum in biotechnology and returning listings[23]. - The company aims to expand its business by leveraging its established foundation in providing high-quality financial printing services as market demand recovers[23]. - The company plans to explore opportunities in the Greater China region and Southeast Asia's emerging innovative industries[21]. - The company is committed to optimizing technology and human resources to pursue excellence in financial printing services[25]. - The company believes that greater diversity and inclusivity will drive its progress and adaptability in the market[22]. - The company has prepared itself to seize long-term opportunities as uncertainties in the macroeconomic environment persist[23]. - The company continues to prioritize delivering high-quality financial printing services to create long-term value for shareholders[23]. Corporate Governance - The company has adopted a share option scheme to reward eligible participants for their contributions to the group[55]. - The company has complied with all applicable corporate governance codes as per GEM listing rules throughout the year[153]. - The company has adopted the corporate governance standards as per GEM Listing Rules, ensuring compliance with all applicable code provisions[162]. - The board consists of five directors, with independent non-executive directors making up 60% of the board members[167]. - The company has implemented a board diversity policy and discussed measurable targets for its implementation[175]. - The independent non-executive directors contributed diverse business and financial expertise to the board[169]. - The company has established a management structure to support effective accountability and governance[165]. - The roles of the Chairman and CEO are distinctly separated to ensure a balanced distribution of power and authority within the board[178]. - The Audit Committee is composed entirely of independent non-executive directors, ensuring objectivity in financial reporting and auditing processes[180]. - The Remuneration Committee is responsible for establishing a transparent process for determining the remuneration policies for directors and senior management[185]. Sustainability and Social Responsibility - The company has adopted a focus on sustainability, prioritizing the well-being of stakeholders during the COVID-19 pandemic while maintaining business operations[22]. - The company has implemented various policies to promote environmental sustainability, aiming to reduce resource consumption and waste[87]. - The company did not make any charitable donations during the year, compared to HKD 5,700 in 2021[151]. Market Position and Competition - The company is considering strategic acquisitions to bolster its market position, with potential targets identified in the industry[71]. - Market expansion plans include entering EE new regions, which are anticipated to increase market share by FF%[71]. - A new marketing strategy has been implemented, focusing on digital channels, which is expected to improve customer engagement by GG%[71]. - The company has achieved a cost reduction of HH% through operational efficiencies, positively impacting overall profitability[71]. Risk Management - The company is committed to maintaining effective risk management and internal control systems to support its financial reporting and compliance obligations[181]. - The management team emphasized the importance of compliance with regulatory standards, ensuring adherence to all relevant laws and regulations[71].
钜京控股(08450) - 2022 - 年度财报